Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 30Rectal Neoplasms 21Esophageal Neoplasms 15Colorectal Neoplasms 15Pancreatic Neoplasms 12Lung Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Prostatic Neoplasms 10Adenocarcinoma Of Esophagus 9Stomach Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Head and Neck Neoplasms 8Sarcoma 7Esophageal Squamous Cell Carcinoma 7Neoplasms 5Colonic Neoplasms 5Central Nervous System Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 5Urinary Bladder Neoplasms 4Inflammatory Breast Neoplasms 4Fallopian Tube Neoplasms 4Breast Neoplasms, Male 4Breast Carcinoma In Situ 4Brain Neoplasms 4Recurrence 3Neoplasm Metastasis 3Kidney Neoplasms 3Glioma 3Glioblastoma 3

Interventions

Haloperidol 2Vitamin E 1Surveys and Questionnaires 1Sodium Chloride 1Sevoflurane 1Propofol 1Pemetrexed 1Paclitaxel 1Olanzapine 1Neoadjuvant Therapy 1Mental Status and Dementia Tests 1Melatonin 1Injections 1Inhalation 1Donepezil 1Dexmedetomidine 1Anesthesia, Spinal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Delirium × Neoadjuvant Therapy × Clear all
NCT05273827 2024-01-05

Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium

Tianjin Medical University Cancer Institute and Hospital

Completed
81 enrolled

Agnosia, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡